Clinical utility of anti-cyclic citrullinated peptid and rheumatoid factor in chronic hepatitis B virus infection

Background: It is necessary to distinguish whether musculoskeletal symptoms are associated with rheumatic diseases or hepatitis virus infection. Rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) may be detected in rheumatic diseases and also during infections. The objective of...

Full description

Saved in:
Bibliographic Details
Main Authors: Gokhan Sargin, Altay Kandemir
Format: Article
Language:English
Published: SAGE Publishing 2018-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2018;volume=13;issue=4;spage=229;epage=232;aulast=Sargin
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832544048567549952
author Gokhan Sargin
Altay Kandemir
author_facet Gokhan Sargin
Altay Kandemir
author_sort Gokhan Sargin
collection DOAJ
description Background: It is necessary to distinguish whether musculoskeletal symptoms are associated with rheumatic diseases or hepatitis virus infection. Rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) may be detected in rheumatic diseases and also during infections. The objective of this study was to evaluate the clinical utility of anti-CCP and RF in patients with chronic hepatitis B virus (HBV) infection. Methods: Ninety-seven patients with chronic HBV infection, 35 patients with rheumatoid arthritis (RA), and 30 healthy controls were included in the study. HBV-DNA, hepatitis B e antigen, anti-HBe, RF, and anti-CCP were evaluated. Results: The rates of positivity for RF and anti-CCP were 14.4% and 4.1% respectively in patients with chronic HBV infection. Arthritis was present in 7 of 97 patients with chronic HBV infection. There was a statistically significant difference for anti-CCP positivity but not for RF positivity between patients with arthritis and without arthritis. No correlation was found between RF and anti-CCP, HBV-DNA, anti-CCP, and HBV-DNA in patients with HBV infection. Conclusions: Anti-CCP positivity was a determinant for polyarthritis in the context of HBV infection. It appears to be a more reliable parameter than RF in differentiating arthritis and nonarthritis group in patients with HBV infection.
format Article
id doaj-art-3d7a6909b5b2460bb968217398f67204
institution Kabale University
issn 0973-3698
0973-3701
language English
publishDate 2018-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Rheumatology
spelling doaj-art-3d7a6909b5b2460bb968217398f672042025-02-03T11:07:28ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012018-01-0113422923210.4103/injr.injr_82_18Clinical utility of anti-cyclic citrullinated peptid and rheumatoid factor in chronic hepatitis B virus infectionGokhan SarginAltay KandemirBackground: It is necessary to distinguish whether musculoskeletal symptoms are associated with rheumatic diseases or hepatitis virus infection. Rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) may be detected in rheumatic diseases and also during infections. The objective of this study was to evaluate the clinical utility of anti-CCP and RF in patients with chronic hepatitis B virus (HBV) infection. Methods: Ninety-seven patients with chronic HBV infection, 35 patients with rheumatoid arthritis (RA), and 30 healthy controls were included in the study. HBV-DNA, hepatitis B e antigen, anti-HBe, RF, and anti-CCP were evaluated. Results: The rates of positivity for RF and anti-CCP were 14.4% and 4.1% respectively in patients with chronic HBV infection. Arthritis was present in 7 of 97 patients with chronic HBV infection. There was a statistically significant difference for anti-CCP positivity but not for RF positivity between patients with arthritis and without arthritis. No correlation was found between RF and anti-CCP, HBV-DNA, anti-CCP, and HBV-DNA in patients with HBV infection. Conclusions: Anti-CCP positivity was a determinant for polyarthritis in the context of HBV infection. It appears to be a more reliable parameter than RF in differentiating arthritis and nonarthritis group in patients with HBV infection.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2018;volume=13;issue=4;spage=229;epage=232;aulast=SarginAnti-cyclic citrullinatedclinical significancehepatitis Brheumatoid factor
spellingShingle Gokhan Sargin
Altay Kandemir
Clinical utility of anti-cyclic citrullinated peptid and rheumatoid factor in chronic hepatitis B virus infection
Indian Journal of Rheumatology
Anti-cyclic citrullinated
clinical significance
hepatitis B
rheumatoid factor
title Clinical utility of anti-cyclic citrullinated peptid and rheumatoid factor in chronic hepatitis B virus infection
title_full Clinical utility of anti-cyclic citrullinated peptid and rheumatoid factor in chronic hepatitis B virus infection
title_fullStr Clinical utility of anti-cyclic citrullinated peptid and rheumatoid factor in chronic hepatitis B virus infection
title_full_unstemmed Clinical utility of anti-cyclic citrullinated peptid and rheumatoid factor in chronic hepatitis B virus infection
title_short Clinical utility of anti-cyclic citrullinated peptid and rheumatoid factor in chronic hepatitis B virus infection
title_sort clinical utility of anti cyclic citrullinated peptid and rheumatoid factor in chronic hepatitis b virus infection
topic Anti-cyclic citrullinated
clinical significance
hepatitis B
rheumatoid factor
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2018;volume=13;issue=4;spage=229;epage=232;aulast=Sargin
work_keys_str_mv AT gokhansargin clinicalutilityofanticycliccitrullinatedpeptidandrheumatoidfactorinchronichepatitisbvirusinfection
AT altaykandemir clinicalutilityofanticycliccitrullinatedpeptidandrheumatoidfactorinchronichepatitisbvirusinfection